Moreover, the DNA amplification and mRNA overexpression in patients with phaeochromocytomas/paragangliomas bearing EPAS1 mutations is indicative of the concerted aberration of EPAS1 in the pathogenesis for this group of tumours. Here, EPAS1 is linked to paraganglioma.